With regard to cancer, Sirt1 was postulated as an anticancer target, e.g., promoting epithelial-to-mesenchymal transition (EMT) in many cancer types (22) but it was also reported to suppress EMT in types like ovarian cancer. The gene discussed is SIRT1; the disease is cancer.